sleep apnea tirzepatide Diabetes drug resolves in up to 52% of patients—is FDA approval in the cards? F.D.A. Approves Weight-Loss Drug to

Beatrice Wihlander GLP-1 use among US adolescents surges, but long-term health effects remain unknown Beatrice Wihlander Key takeaways GLP-1 weight loss medication use among US adolescents and young adults receiving obesity treatment increased between 2022 and 2026, while MBS declined

Obese mice exhibited lower baseline expression of 3-AR in both fat types compared to lean controls

BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology

In the past I could waste HOURS with just going through posts, videos, etc

While some patients achieve stable outcomes with minimal contact, others require more intensive and ongoing psychotherapy, underscoring the need for a steppedcare approach tailored to psychosocial vulnerabilities and evolving needs [146]

MacDonald, B